Six cases of fatal pneumococcal sepsis are described, occurring in the
post-allograft setting, between 3 and 39 months after transplantation
. Five of the six patients were suffering from chronic graft-versus-ho
st disease and were receiving immunosuppressive therapy, Most were rec
eiving prophylactic antibiotic therapy, This represents approximately
2% of the allograft population treated during the study period who sur
vived for >3 months after transplant, Pneumococcal sepsis is thus stil
l a significant cause of death after allogeneic BMT and approaches to
minimise its occurrence are discussed.